Compass Therapeutics (CMPX) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.11
-0.1
-0.09
-0.08

Details

Expected EPS
-0.112857
Actual EPS
-0.08
Surprise EPS
0.03
Surprise Percent
+29.11%

Description

Compass Therapeutics (CMPX) has reported earnings of -0.08 per share for Q4 2024.

0 Comments

Share your thoughts